The estimated Net Worth of Sheldon Trainor Degirolamo is at least $5.22 Millón dollars as of 14 March 2019. Sheldon Degirolamo owns over 54,085 units of Athenex Inc stock worth over $122,267 and over the last 7 years Sheldon sold ATNX stock worth over $5,102,469.
Sheldon has made over 7 trades of the Athenex Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently Sheldon sold 54,085 units of ATNX stock worth $636,580 on 14 March 2019.
The largest trade Sheldon's ever made was selling 121,688 units of Athenex Inc stock on 15 May 2018 worth over $2,069,913. On average, Sheldon trades about 33,200 units every 30 days since 2017. As of 14 March 2019 Sheldon still owns at least 611,333 units of Athenex Inc stock.
You can see the complete history of Sheldon Degirolamo stock trades at the bottom of the page.
Sheldon's mailing address filed with the SEC is C/O ATHENEX, INC., 1001 MAIN STREET, SUITE 600, BUFFALO, NY, 14203.
Over the last 7 years, insiders at Athenex Inc have traded over $33,215,399 worth of Athenex Inc stock and bought 5,920,005 units worth $73,651,360 . The most active insiders traders include Advisors Llcperceptive Life..., Song Yi Zhang y Song Yi Mandra Medical Ltd .... On average, Athenex Inc executives and independent directors trade stock every 12 days with the average trade being worth of $10,843. The most recent stock trade was executed by Joe Annoni on 22 February 2023, trading 625 units of ATNX stock currently worth $125.
athenex is a global specialty oncology pharmaceutical company focused on the development and commercialization of next generation therapies for cancer diseases and supportive therapies. the company is dedicated to delivering innovative drugs that can have a life-changing impact on cancer patients. our business includes medical technology innovation centers and a unique manufacturing supply chain across both china and north america. through the connected innovation and manufacturing supply chain presence, we can identify, develop and deliver proprietary medical technology across continents and multiple regulatory environments.
Athenex Inc executives and other stock owners filed with the SEC include: